Post-earnings recap
Reported
Thu, Jul 31, 2025
EPS actual
$1.46
EPS est.
$1.67
EPS surprise
-12.63%
1-day move
-5.81%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bristol Myers Squibb's earnings report showed a significant miss on EPS, which contributed to a 5.81% decline in stock price. Investors may be concerned about the company's current challenges and lack of guidance. The management's defensive tone suggests that they are aware of the hurdles ahead but remain focused on long-term growth strategies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.46 | N/A | -12.63% |
Management expressed concerns about current market conditions impacting performance. They reiterated their commitment to innovation and pipeline development.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term strategies despite short-term setbacks.